Companies / Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc.

APLSCIK 1492422WALTHAM, MA

Financials · FY2025

Revenue$1.00B
Net income$22.39M
Total debt$93.11M
Cash$405.21M
Diluted EPS$0.20
Shares outstanding128.0M

Ownership

128.0M shares outstanding · as of Apr 30, 2026
2.8%Insiders
Ownership
Insiders2.77%3,550,719
10%+ / strategic10.33%13,228,073
Institutions104.59%133,897,030
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
Deschatelets PascalChief Scientific Officer
0.92%1,177,222
Francois CedricCEOChief Executive Officer · Director
0.62%798,783
Machiels AlecDirector
0.30%384,989
Dunlop A. SinclairDirector
0.13%161,567
Sullivan Timothy EugeneChief Financial Officer
0.12%152,041
Watson David O.General Counsel
0.11%144,517
Boucher KelleyChief People Officer
0.10%127,804
Nicholson NurChief Technical Officer
0.09%116,338
DeLong Mark JeffreyChief Business & Strat Officer
0.09%114,591
Meltzer LeslieChief Research and Development
0.08%107,024

Institutional holders 311

View all →
HolderValue% of shares
Wellington Management Group LLP$319.56M9.94%
Avoro Capital Advisors LLC$307.02M9.55%
Vanguard Group Inc$268.15M8.34%
Morgan Stanley$230.43M7.17%
Deep Track Capital, LP$194.68M6.05%
RTW Investments, LP$192.59M5.99%
BlackRock, Inc.$157.25M4.89%
Hbk Investments L P$142.82M2.77%
State Street Corporation$115.89M3.60%
UBS Group AG$105.16M3.27%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 22, 2026Francois Cedric
CEO
SellCommon Stock$591.8K-27K
-8.68%
286,045
0.22% of shares
medium
Jan 13, 2026Francois Cedric
CEO
SellCommon Stock$226.0K-10K
-3.07%
321,419
0.25% of shares
medium
Jan 22, 2026Sullivan Timothy Eugene
Executive
SellCommon Stock$223.9K-10K
-9.87%
93,901
0.07% of shares
medium
Jan 22, 2026Watson David O.
Executive
SellCommon Stock$170.5K-8K
-8.13%
88,531
0.07% of shares
medium
Jan 22, 2026Nicholson Nur
Executive
SellCommon Stock$168.1K-8K
-9.80%
71,118
0.06% of shares
medium
Jan 20, 2026Francois Cedric
CEO
SellCommon Stock$161.9K-8K
-2.55%
313,237
0.24% of shares
medium
Jan 22, 2026Deschatelets Pascal
Executive
SellCommon Stock$129.0K-6K
-0.51%
1,151,382
0.90% of shares
medium
Jan 13, 2026Watson David O.
Executive
SellCommon Stock$128.2K-6K
-5.52%
98,838
0.08% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BlackRock, Inc.Passive13G—13,228,073—
RTW Investments, LPPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
APLS——03753U106—